Product Profiles: Marketed Antibacterials – Increasing Genericization and Fragmentation Shape a Crowded Market – new market research report – Transworld News

Levaquin, the biggest-selling antibacterial globally garnering sales over $2.5bn in 2010, lost patent protection in 2011, constituting a major blow to the marketing partners Johnson & Johnson, Daiichi Sankyo and Sanofi. Datamonitor expects generic …